LETERMOVIR FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN ADULT CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

被引：0
|
作者：
Duarte, R. [1 ,2 ]
Marty, F. [3 ]
Ljungman, P. [4 ]
Chemaly, R. [5 ]
Maertens, J. [6 ]
Snydman, D. [7 ]
Blumberg, E. [8 ]
Einsele, H. [9 ]
Boeckh, M. [10 ]
Teal, V. [11 ]
Wan, H. [11 ]
Kartsonis, N. [12 ]
Leavitt, R. [12 ]
Badshah, C. [12 ]
机构：
[1] Hosp Univ Puerta Hierro, BMT Programme, Barcelona, Spain
[2] Hosp Univ Puerta Hierro, Myeloid Leukemia Div, Barcelona, Spain
[3] Dana Farber Canc Inst, Div Infect Dis, Boston, MA 02115 USA
[4] Karolinska Univ Hosp, Hematol, Stockholm, Sweden
[5] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[6] Univ Ziekenhuizen, Hematol, Leuven, Belgium
[7] Tufts Med Ctr, Med, Boston, MA USA
[8] Univ Penn, Infect Dis Div, Perelman Sch Med, Philadelphia, PA 19104 USA
[9] Univ Klinikum Wurzburg, Internal Med, Wurzburg, Germany
[10] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA
[11] Merck & Co Inc, Late Dev Stat, Kenilworth, NJ USA
[12] Merck & Co Inc, Global Clin Dev Infect Dis, Kenilworth, NJ USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S807
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [1] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [2] A Single Center Experience of Letermovir for the Prevention of CMV Infection in CMV-Seropositive Allogeneic Cell Transplant (Allo-HCT) Recipients
    Foolad, Farnaz
    Shigle, Terri Lynn
    Handy, Victoria Wehr
    Khawaja, Fareed
    Aitken, Samuel L.
    Chemaly, Roy F.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [3] Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
    Foolad, Farnaz
    Aitken, Samuel L.
    Chemaly, Roy F.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (10) : 931 - 941
  • [4] Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation
    De latour, Regis Peffault
    Chevallier, Patrice
    Blaise, Didier
    Clement, Aurore
    Allavoine, Thierry
    Tadmouri, Abir
    Blomkvist, Josefin
    Duhamel, Alain
    Yakoub-Agha, Ibrahim
    [J]. BLOOD, 2018, 132
  • [5] Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV-seropositive patients after allogeneic hematopoietic cell transplantation
    Cohen, L.
    Yeshurun, M.
    Shpilberg, O.
    Ram, R.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (04) : 510 - 517
  • [6] Cost Effectiveness of Letermovir in Prevention of Clinically Significant CMV Infection in CMV Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 12 - 13
  • [7] Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation
    Peffault De Latour, Regis
    Chevallier, Patrice
    Blaise, Didier
    Alami, Sarah
    Levy-Bachelot, Laurie
    Allavoine, Thierry
    Tadmouri, Abir
    Blomkvist, Josefin
    Duhamel, Alain
    Srour, Micha
    Beauvais, David
    Yakoub-Agha, Ibrahim
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (12) : 3665 - 3673
  • [8] Is Cytomegalovirus (CMV) Infection Really Dangerous in CMV-Seropositive Adult Liver Transplant Recipients?
    Kim, Jong Man
    Shin, Milljae
    Moon, Ju Ik
    Choi, Gyu-Seong
    Hong, Seune Heui
    Kwon, Choon Hyuck D.
    Kim, Sung-Joo
    Joh, Jae-Won
    Lee, Suk-Koo
    [J]. LIVER TRANSPLANTATION, 2010, 16 (06) : S84 - S84
  • [9] Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R plus ) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (pts)
    Dadwal, Sanjeet S.
    Al Malki, Monzr M.
    Yang, Dongyun
    Tegtmeier, Bernard R.
    Ross, Justine
    Mokhtari, Sally
    Marcucci, Guido
    Palmer, Joycelynne
    Salhotra, Amandeep
    Dickter, Jana
    O'Donnell, Margaret R.
    Smith, Eileen
    Karanes, Chatchada
    Snyder, David S.
    Mei, Matthew
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Stein, Anthony S.
    Sandhu, Karamjeet S.
    Spielberger, Ricardo
    Nademanee, Auayporn
    Ito, James I.
    Forman, Stephen J.
    Zaia, John A.
    Nakamura, Ryotaro
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
12345